12:00 AM
 | 
Dec 16, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Bronchitol mannitol regulatory update

The Scottish Medicines Consortium recommended the restricted use of Bronchitol mannitol on the National Health Service (NHS) in Scotland as add-on to standard of care in adult patients with cystic fibrosis. The formulation of mannitol in a dry powder inhaler system is recommended only in patients...

Read the full 210 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >